Data Horizon Co

Data Horizon Co Forward P/E

The Forward P/E Ratio of Data Horizon Co (3628.T) as of Oct 28, 2026 is 22.63. In the previous year, Forward P/E Ratio was -1.53 — a change of -1,574.70% (higher).

Forward P/E

22.63

YoY

-1,574.70%

Last updated:

Forward P/E Ratio of Data Horizon Co is 2026 22.63 . Forward P/E Ratio of Data Horizon Co was 2025 -1.53 . It decreases by -1,574.70% higher compared to the previous year.

The Data Horizon Co Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2019
284.70 JPY
Jan 1, 2020
30.06 JPY
Jan 1, 2021
21.36 JPY
Jan 1, 2022
-14.77 JPY
Jan 1, 2023
-9.12 JPY
Jan 1, 2024
-7.51 JPY
Jan 1, 2025
-1.53 JPY
Jan 1, 2026
22.63 JPY
The Data Horizon Co Forward P/E history
YEARForward P/EYoY
22.63-1,574.70%
-1.53-79.58%
-7.51-17.63%
-9.12-38.21%
-14.77-169.11%
21.36-28.94%
30.06-89.44%
284.70+888.50%
28.80-51.58%
59.49-634.36%
-11.13-97.79%
-504.71+202.56%
-166.81—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Data Horizon Co Stock analysis

What does Data Horizon Co do? Data Horizon Co., Ltd generates revenue through its Medical-related Information segment, which offers medical-related information services and systems. The company develops software utilizing its proprietary medical databases, primarily targeting insurers with data health-related services. These services include analyzing insurers' receipt and medical checkup data to create health plans, optimize medical expenses, and promote health initiatives, such as notifying about generic drug usage. Additionally, Data Horizon provides a new polypharmacy service as part of its offerings. The company's primary customers are insurers, who purchase the data health services to support their healthcare business operations. Insurers use the data to analyze medical checkup trends, optimize spending, and implement health promotion strategies. The information systems developed by Data Horizon are tailored to meet the specific needs of insurers, enabling them to manage healthcare costs more effectively. Data Horizon's product portfolio includes medical-related information systems, data health services, and a new polypharmacy service. The medical-related information services focus on software solutions that process and analyze medical data, while the polypharmacy service addresses medication management for patients. These offerings are designed to support insurers in improving healthcare efficiency and reducing costs through data-driven insights. Data Horizon Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Data Horizon Co stock

Forward P/E Ratio of Data Horizon Co is 22.63 in 2026.

Forward P/E Ratio of Data Horizon Co changed from -1.53 to 22.63, representing a -1,574.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Data Horizon Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Data Horizon Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Data Horizon Co

All Key Metrics — Data Horizon Co